Frontline of science and technology
Innovation has been always the emphasis of our enterprise culture as of establishment of our company, and the technological innovation has been a focus of the emphasis thereof. Its laboratory has applied for 15 national patents in total, 3 authorized and 9 under substantive investigation, as of establishment of Department of Research and Development of Neptunus Interlong Biotechnique Co. LTD. Many a paper written by the staff members has been issued by more advanced academic periodicals at home and abroad; 2 innovative drugs with proprietary intellectual property right, 5 new dosage forms and 2 new type second generation vaccines have been developed, several innovative technologies being supported and awarded by governments.

Research projects
Department of Research and Development puts an emphasis on the development of innovative drugs with proprietary intellectual property right and industrialization of vaccines, whose leading direction is drugs for treatment of liver disease and tumor and vaccines for main pandemics. At present, the products in process include innovative drugs of gene-engineering cytokine, vaccines including influenza vaccine, rabies vaccine and Hemophilus Influenza B Polysaccharide Conjugated Vaccine, and new dosage form protein drugs.